Autoimmunity a pathway to usual interstitial pneumonia?

Chest

Volumn 148, Issue 6, 2015, Pages 1367-1369

  Schwarz, Marvin ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ALLERGIC PNEUMONITIS; ANTIBODY BLOOD LEVEL; ANTIBODY SCREENING; ASBESTOSIS; AUTOIMMUNITY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; EDITORIAL; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG INFILTRATE; PRIORITY JOURNAL; SURVIVAL PREDICTION; THORAX RADIOGRAPHY; CONNECTIVE TISSUE DISEASES; FEMALE; INTERSTITIAL LUNG DISEASE; LUNG; MALE;

CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE;

EID: 84948970422     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-1323     Document Type: Editorial

References (12)

1. Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med. 2007;28(4): 369-378.
2. Fischer A, West SG, Swigris JJ, Brown K K, du Bois R M. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest. 2010;138(2):251-256.
3. Kinder BW, Collard HR, Kolb L, et al. Idiopathic nonspecif c interstitial pneumonia: lung manifestation of an undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007;176(7):691-697.
4. Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011;140(5):1292-1299.
5. Omote N, Taniguchi H, Kondoh Y, et al. Lung-dominant connective tissue disease: clinical, radiologic, and histologic features. Chest. 2015;148(6):1438-1446.
6. Sverzellati N, Wells AU, Tomasetti S, et al. Biopsy-proved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology. 2010;254(3):957-964.
7. Park JH, Kim D S, Park IN, et al. Prognosis off brotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007;175(7):705-711.
8. Dreisin RB, Schwarz MI, Teoflopoulos AN, Stanford RE. Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med. 1978;298(7):353-357.
9. Gu H, Mickler EA, Cummings OW, et al. Crosstalk between TGF-b 1 and complement activation augments epithelial injury in pulmonary fibrosis. FASEB J. 2014;28(10):4223-4234.
10. Shum AK, Alimohammadi M, Tan CL, et al. BPIFBI is a lung-specif c autoantigen associated with interstitial lung disease. Sci Transl Med. 2013;5(206):206ra139.
11. Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364(16): 1503-1512.
12. Peljto AL, Steele MP, Fingerlin TE, et al. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis. Chest. 2012;142(6):1584-1588.